Physicians' Academy for Cardiovascular Education

How to manage DOAC-related bleeding

10' education - Mar. 8, 2018 - Prof. Menno Huisman (The Netherlands) and dr. Alexander Cohen (UK)

Video navigation menu

  • Is management of DOAC-related bleeding different from a bleeding on warfarin? 0:25
  • Is it necessary to classify patients or the bleeding, to know how to act? 1:06
  • Having a hospital-specific protocol on management of DOAC- or VKA-related bleeding is important 2:12
  • Renal function shoulds be assessed in the context of DOAC treatment 3:54
  • Outcomes of patients who bleed on DOACs, in the context of reversal agents 4:17


Prof. Menno Huisman - LUMC, Leiden, The Netherlands

Alexander Cohen, MD King's College, London, United Kingdom


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme. Funding was provided by an unrestricted educational grant from Pfizer/BMS.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: